MIVI Neuroscience's R4Q Catheter for Ischemic Stroke Approved and Commercialized in Europe

 

July 2, 2018—MIVI Neuroscience, Inc. announced the expansion of its European commercialization network for the R4Q revascularization catheter for the treatment of ischemic stroke.

The R4Q system's suite of devices, which received European CE Mark approval in March, will be introduced with a focused launch through a network of experienced neurovascular distribution partners. Most recently, the company received a commitment from AngioNautix of Madrid, Spain, to be its partner in Spain, Portugal, and Cuba. MIVI is also partnered with Neurologic Europe Ltd. in the United Kingdom, and Med-Italia Biomedica, S.r.l. in Italy.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.